Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Generalized Anxiety Disorder Recent news which mentions Generalized Anxiety Disorder Psychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In Colorado March 22, 2024 Tickers CCC IXHL Tags Psychedelic Natural Medicine Health Act Heroic Hearts Project From Benzinga MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials March 07, 2024 Tickers CMPS MNMD NEWS Tags FDA Psychedelic/Assisted Therapies Legal From Benzinga Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treating Generalized Anxiety February 28, 2024 Tickers IXHL NEWS Tags Psychedelics Research IXHL Management From Benzinga MindMed's 2024 Plans: Anxiety Treatment Stands, LSD Microdosing For ADHD Will Be Discontinued January 11, 2024 Tickers MNMD NEWS Tags Psychedelic/Assisted Therapies Generalized Anxiety Disorder MNMD From Benzinga Groundbreaking Study: LSD Tartrate Reduces Anxiety Effectively, Says MindMed December 14, 2023 Tickers MNMD Tags Psychedelic/Assisted Therapies FDA Management From Benzinga MindMed's Phase 2b Trial For MM-120 In GAD Reaches Enrollment Milestone September 12, 2023 Tickers MNMD Tags Benzinga Psychedelics MNMD From Benzinga MindMed's LSD Study For Anxiety Treatment Enrolls And Doses 100 Participants, More Expected May 19, 2023 Tickers MNMD Tags News Penny Stocks LSD Therapy From Benzinga Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released May 09, 2023 Tickers CYBN Tags News Penny Stocks major depressive disorder From Benzinga Psychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder March 15, 2023 Tickers FLHLF IXHL SILO Tags Psychedelics Benzinga Generalized Anxiety Disorder From Benzinga Two New Studies On Classical Psychedelics: Grading Ketamine's Components, Tuning Down Psilocybin Dosing January 24, 2023 Tickers AWKNF Tags Benzinga Psychedelics AWKNF From Benzinga Australian Psychedelics: Phase 2 Trial On Psilocybin For Anxiety Will Soon Share Results January 18, 2023 Tickers IXHL Tags Markets Market News Cannabis From Benzinga Psychedelics Companies Join The Race To Develop Much-Needed Anxiety Treatment January 16, 2023 Tickers CYBN Tags anxiety disorders CYBN DMT Entities From Benzinga Where Are Psychedelics Headed In 2023? These Two Heavy Hitters Share Their Plans January 09, 2023 Tickers CYBN MNMD Tags Benzinga Psychedelics Psilocybin program From Benzinga What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways January 03, 2023 Tickers ATAI AWKNF CMND CMPS Tags Psychedelics Psychedelics Investing Legal From Benzinga MindMed's First Patient Dosing Clinical Trial With LSD For Treatment Of Generalized Anxiety Disorder August 25, 2022 Tickers MNMD Tags Psychedelics Benzinga MindMed From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.